Today's Wall Street Journal is a Monday paper — it reports last week's close (S&P 7,126.06, DJIA 49,447.43, NASDAQ 24,468.48 all at records), but the forward-looking content is what matters. Four separate stories on the front section change or reinforce how we are running portfolios this week. This commentary covers each one with the "what it means for our book" read.
1. Iran Endgame Is Not Done
Vice President JD Vance arrives in Pakistan tonight with Steve Witkoff and Jared Kushner for Tuesday peace talks with Iran. Iran was, as of Sunday, still threatening to skip the session, saying U.S. demands "remain excessive." The cease-fire expires Tuesday night. U.S. Central Command confirmed Sunday that an Iranian-flagged ship was seized in the Gulf of Oman — it was attempting to slip past the U.S. blockade. More than 20 such vessels have been turned back. Trump warned Sunday that Iran would face strikes destroying "power plants and bridges" if a deal isn't reached. U.A.E. has quietly opened talks with the U.S. about a financial backstop should Gulf states get dragged in.
What moved: Oil futures climbed back near $90 in Sunday trading (from Friday close of $83.85). Stock-index futures fell ~1%. Our energy sleeve (XOM, CVX, COP, MPC, LNG) stays at 18% — no change.
2. Big Oil Is Redirecting $120B Away From The Middle East
Wood Mackenzie estimates Exxon, Chevron, BP, TotalEnergies and peers will together create $120B in value from exploration ventures outside the Persian Gulf in coming years. Specifics from today's paper:
- Exxon: up to $24B into Nigerian deep-water fields
- Chevron: expanded Venezuela footprint (U.S. license-permitted)
- BP: bought stakes in oil blocks off Namibia
- TotalEnergies: exploration deal with Turkey
Energy Secretary Chris Wright and Interior Secretary Doug Burgum personally pushed majors last week to keep bolstering output ahead of a looming supply shortfall. The romance of frontier drilling is back — because after cash returns to shareholders, they finally have the war chest to do it.
Book implications: CAPEX discipline holds for XOM/CVX integrated majors; overweight independents (COP, MPC) that benefit from higher WTI without frontier risk. Our Energy 18% stays, but tactically tilt toward domestics vs. Supermajors until M&A activity confirms the Africa/SA pivot actually monetizes.
3. Greg Ip Calls The Manufacturing Stealth Boom
Front-page "Capital Account" column — America is seeing a manufacturing revival that neither critics nor fans of Trump will acknowledge. Since January 2025, manufacturing jobs fell ~100,000 (-0.6%) but manufacturing production rose 2.3% and shipments +4.2%. AI-related and aerospace manufacturing (Boeing deliveries +72% last year to 600 jetliners) had a great year. McKinsey Global Institute data shows domestic production of computer and electronic products up 7.7% in Q4 2025 YoY, but imports also up 40.5% — AI demand is big enough that it's complementing rather than displacing imports.
Watchlist add: Vertiv (VRT). Named specifically in today's article — data center power management, cooling, server rack infrastructure. Serves domestic and Mexican facilities. We already own VRT inside the AI/Cyber/Data sleeve. Also reinforces: HON, GE, CAT, ETN, ROK as domestic industrial plays.
4. Verizon CEO Publicly Warns On AI Unemployment
Dan Schulman announced 13,000 layoffs last week and told other CEOs to be candid about AI-driven job losses. He forecasts 20-30% U.S. unemployment within 2-5 years and warns humanoid robots will upend manual-labor roles still considered safe. This is a sea change — a sitting big-cap CEO publicly staking out a number. Salesforce's Benioff, separately in today's paper, said AI is making Salesforce more valuable to customers than ever.
Planning impact for our book: adjust income-replacement modeling assumptions. For pre-retirees in AI-exposed roles (admin, entry-level finance, customer service), bump the probability of early involuntary retirement up. Social Security credit gap analysis becomes more important. LTC conversations get easier.
Themes Check — Seven-For-Seven, Plus Two Candidates
✓ Hold
Big Oil frontier spend + Iran risk premium keep XOM/CVX/COP/LNG/MPC core. Near-$90 futures this morning.
✓ Hold
Groton submarine capacity headline today — General Dynamics adding 8,000 workers. RTX, LMT, NOC, GD stay.
✓ Hold
Kessler's Viz.ai piece, Benioff's AI pivot, Cerebras IPO, Vertiv domestic footprint. NVDA, META, PLTR, VRT, CRWD, PANW.
✓ Hold
Salesforce -28% YTD creates the backdrop; private credit growing via Bilt deal with Blue Owl/Stone Point. JPM, GS, KKR, APO.
✓ Hold
Manufacturing boom validates ETN, ROK, VRT, CARR, HON, CAT exposure. Continues to track.
✓ Hold
Gold still at $4,857 ATH. Iran risk, dollar weakness, UAE backstop talk. GLD, NEM core.
✓ Hold
KO, PEP, WMT, COST — stable as ever. Kelonia deal and pharma front-page prompt a healthcare add (LLY, ABBV).
Proposed 8th & 9th Themes
8th Theme — Nuclear & Critical Minerals (holdover from Apr 18)
Power demand from AI data centers makes SMR nuclear a structural story. CEG (Constellation), VST (Vistra), OKLO (SMR), CCJ (Cameco uranium), MP (MP Materials rare earths). 5% proposed weight. Validation this week: Cerebras IPO + Verizon's AI workforce comments both tell us the compute buildout is not slowing.
9th Theme — Water Infrastructure & Desalination
Still on the docket from last weekend's Cross Country column. XYL (Xylem picks-and-shovels), AWK (American Water Works regulated utility), WTR (Essential Utilities), WMS (Advanced Drainage), PCYO (Pure Cycle desalination small-cap). 3% proposed weight. Validation: nothing today, but California water and Colorado River structural gaps are unchanged.
10th Theme Candidate — Healthcare Innovation / Oncology
New this week. Today's A3 brings two major KRAS-mutation lung cancer drug trial readouts (Revolution Medicines zoldonrasib, D3 Bio elisrasib). Tumors shrank in ~50% of patients with advanced cancer. Plus: Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for $2B+ (CAR-T multiple myeloma). Plus: Trump signed a Saturday EO fast-tracking psychedelic drugs (LSD, ibogaine) for PTSD. RMED, BMY, AMGN, LLY, RXRX (AI-drug-discovery). 4% proposed weight. Bring to Apr 30 review.
What We Are Talking About With Clients This Week
- Iran cease-fire expires Tuesday. Energy sleeve is already at policy weight. Don't chase oil above $90 — it has been there before and retraced twice.
- Kelonia/Eli Lilly deal. If you hold LLY, no change. If you don't, the deal signals Lilly's aggressive build-out of oncology — add it to the watchlist.
- Schulman's AI warning. For pre-retirees in admin/operations/finance roles: let's review your income-replacement model before year-end. That's a real conversation.
- Stealth manufacturing boom. VRT, HON, GE, CAT, ETN, ROK are all on our domestic industrial list. Not a new buy signal — a reaffirmation of existing weights.
- 9 specialty reads published today. Kessler on Viz.ai, Mackintosh on one-offs, O'Grady on Venezuela, Gay on LIV Golf, Ip on manufacturing, Finley, Fryer, R&O Yale, and Hart's Bookshelf on Sutton. Read the ones that touch your sleeve.
Watchlist Adds From Today's Paper
- VRT (Vertiv) — already in AI/Power sleeve; Ip column validates positioning
- LLY (Eli Lilly) — Kelonia deal. Add to healthcare watchlist
- RMED (Revolution Medicines) — KRAS drug trial data; speculative
- GD (General Dynamics) — Electric Boat submarine ramp; defense core
- CEG, VST, OKLO, CCJ, MP — 8th theme basket (nuclear & critical minerals)
- XYL, AWK, WTR, WMS, PCYO — 9th theme basket (water infrastructure)
Specialty Reads Published Today
Every specialty column in today's paper gets its own page. One article, one page, one index card. Read the ones that touch you:
- Andy Kessler — Viz.ai and AI healthcare pathways (Inside View, A13)
- James Mackintosh — Why the S&P rally rests on one-offs (Streetwise, B1)
- Mary Anastasia O'Grady — The Trouble in Trump's Venezuela (Americas, A13)
- Jason Gay — How should LIV be remembered (Sports, A16)
- Greg Ip — America's stealth manufacturing boom (Capital Account, A1)
- Allysia Finley — Democrats and the Swalwell moment (Life Science, A15)
- Roland Fryer — The Economics of Religion (Opinion, A15)
- Review & Outlook — Yale Takes Itself to Reform School (A14)
- D.G. Hart — Bookshelf: Sutton's Chosen Land (A13)